Diabetic macular oedema (DMO) is a complication of diabetic retinopathy and one of the most common causes of visual impairment in people with diabetes. Clinically significant macular oedema (CSMO) is the most severe form of DMO. Intravitreal antiangiogenic therapy is now the standard treatment for DMO involving the centre of the macula, but laser photocoagulation is still used in milder or non-central DMO.
Monotherapy laser photocoagulation for diabetic macular oedema / Jorge, Eliane C; Jorge, Edson N; Botelho, Mayra; Farat, Joyce G; Virgili, Gianni; El Dib, Regina. - In: COCHRANE LIBRARY. - ISSN 1465-1858. - ELETTRONICO. - 10:(2018), pp. CD010859-CD010859. [10.1002/14651858.CD010859.pub2]
Monotherapy laser photocoagulation for diabetic macular oedema
Virgili, Gianni;
2018
Abstract
Diabetic macular oedema (DMO) is a complication of diabetic retinopathy and one of the most common causes of visual impairment in people with diabetes. Clinically significant macular oedema (CSMO) is the most severe form of DMO. Intravitreal antiangiogenic therapy is now the standard treatment for DMO involving the centre of the macula, but laser photocoagulation is still used in milder or non-central DMO.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
